nivolumab,durvalumab,pembrolizumab,atezolizumab
roche,astrazeneca,bms,merck
['atezo', 'durva', 'nivolumab', 'pembro', 'able,(-kable),(-eable)', 'nivo']
this slide was just shared by at #esmo22 and it supplements the table above. - atezolizumab: sp142 ventana - pembrolizumab: 22c3 dako
- nivolumab: 28-8 dako
- durvalumab: sp263 ventana 
Practice changing #Oncology news from #CommunityOncologists perspective w/ Rohit Gosain @UPMCHillmanCC & Rahul Gosain @WilmotCancer. Views are our own.